Startups
Synthetic Biology inspired Medicines We design and engineer microbial strains rationally to manufacture or as medicines for infectious diseases, cancer and beyond.
Overview
Location
China
Employees
51-200
Total raised
$14M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 6, 2026 | Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia | SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received ... |
| Mar 11, 2021 | Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines | SHANGHAI, March 11, 2021 /PRNewswire/ -- Delonix Bioworks Ltd. (Delonix), a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a $14 million Series Seed financin... |
| Mar 11, 2021 | Delonix Bioworks Raises $14M in Seed Financing | Delonix Bioworks Ltd., a Shangai, China-based biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, closed a $14m seed financing. The round was led by Boehringer Ingelheim Venture Fund... |
Reviews 0
FAQ about Delonix Bioworks Ltd.
How much funding has Delonix Bioworks Ltd. raised?
Delonix Bioworks Ltd. has raised $14M in total across 1 funding round.
What has the press written about Delonix Bioworks Ltd.?
Parsers VC has collected 4 articles mentioning Delonix Bioworks Ltd., among them “Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia” (Feb 6, 2026) and “Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines” (Mar 11, 2021).
Is Delonix Bioworks Ltd. still active?
Yes, Delonix Bioworks Ltd. is active; its latest activity on Parsers VC dates from Jul 13, 2026.